{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:05:04Z","timestamp":1793135104828,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Basic and Applied Basic Research Foundation of Guangzhou, China","award":["2023A04J0523"],"award-info":[{"award-number":["2023A04J0523"]}]},{"DOI":"10.13039\/501100010256","name":"GuangZhou Municipal Science and Technology Project","doi-asserted-by":"crossref","award":["No. 202201010343 to X.S. Peng"],"award-info":[{"award-number":["No. 202201010343 to X.S. Peng"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203538"],"award-info":[{"award-number":["82203538"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012865"],"award-info":[{"award-number":["2024A1515012865"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s11010-025-05241-y","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T14:31:38Z","timestamp":1740839498000},"page":"4135-4148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["TCF7 functions as a prognostic biomarker in bladder cancer by strengthening EMT and stemness associated with TGF-\u03b2\/SMAD3 signaling"],"prefix":"10.1007","volume":"480","author":[{"given":"Congcong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengnan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingsi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanquan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"key":"5241_CR1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M, Mostafid H, Porten S, Psutka SP, Gupta S, Smith AB, Williams SB, Lotan Y (2022) Epidemiology, screening, and prevention of bladder cancer. Eur Urol Oncol 5:628\u2013639. https:\/\/doi.org\/10.1016\/j.euo.2022.10.003","journal-title":"Eur Urol Oncol"},{"key":"5241_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, Lotan Y (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63:234\u2013241. https:\/\/doi.org\/10.1016\/j.eururo.2012.07.033","journal-title":"Eur Urol"},{"key":"5241_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/jama.295.3.299","volume":"295","author":"HB Grossman","year":"2006","unstructured":"Grossman HB, Soloway M, Messing E, Katz G, Stein B, Kassabian V, Shen Y (2006) Surveillance for recurrent bladder cancer using a point-of-care proteomic assay. JAMA 295:299\u2013305. https:\/\/doi.org\/10.1001\/jama.295.3.299","journal-title":"JAMA"},{"key":"5241_CR4","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1002\/jcp.26916","volume":"234","author":"N Aghaalikhani","year":"2019","unstructured":"Aghaalikhani N, Rashtchizadeh N, Shadpour P, Allameh A, Mahmoodi M (2019) Cancer stem cells as a therapeutic target in bladder cancer. J Cell Physiol 234:3197\u20133206. https:\/\/doi.org\/10.1002\/jcp.26916","journal-title":"J Cell Physiol"},{"key":"5241_CR5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871\u2013890. https:\/\/doi.org\/10.1016\/j.cell.2009.11.007","journal-title":"Cell"},{"key":"5241_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.canlet.2012.02.010","volume":"322","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Wang Z, Yu J, Shi J, Wang C, Fu W, Chen Z, Yang J (2012) Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer. Cancer Lett 322:70\u201377. https:\/\/doi.org\/10.1016\/j.canlet.2012.02.010","journal-title":"Cancer Lett"},{"key":"5241_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/ijms17010043","volume":"17","author":"T Ohishi","year":"2015","unstructured":"Ohishi T, Koga F, Migita T (2015) Bladder cancer stem-like cells: their origin and therapeutic perspectives. Int J Mol Sci 17:43. https:\/\/doi.org\/10.3390\/ijms17010043","journal-title":"Int J Mol Sci"},{"key":"5241_CR8","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1158\/1078-0432.CCR-20-4796","volume":"27","author":"H Wang","year":"2021","unstructured":"Wang H, Mei Y, Luo C, Huang Q, Wang Z, Lu GM, Qin L, Sun Z, Huang CW, Yang ZW et al (2021) Single-cell analyses reveal mechanisms of cancer stem cell maintenance and epithelial-mesenchymal transition in recurrent bladder cancer. Clin Cancer Res 27:6265\u20136278. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-4796","journal-title":"Clin Cancer Res"},{"key":"5241_CR9","doi-asserted-by":"publisher","first-page":"e21549","DOI":"10.1096\/fj.202002566R","volume":"35","author":"J Zhang","year":"2021","unstructured":"Zhang J, Lyu T, Cao Y, Feng H (2021) Role of TCF-1 in differentiation, exhaustion, and memory of CD8(+) T cells: a review. FASEB J 35:e21549. https:\/\/doi.org\/10.1096\/fj.202002566R","journal-title":"FASEB J"},{"key":"5241_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/jclinpath-2019-205698","volume":"72","author":"Y Zhan","year":"2019","unstructured":"Zhan Y, Feng J, Lu J, Xu L, Wang W, Fan S (2019) Expression of LEF1 and TCF1 (TCF7) proteins associates with clinical progression of nasopharyngeal carcinoma. J Clin Pathol 72:425\u2013430. https:\/\/doi.org\/10.1136\/jclinpath-2019-205698","journal-title":"J Clin Pathol"},{"key":"5241_CR11","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2147\/CMAR.S187219","volume":"11","author":"D Chen","year":"2019","unstructured":"Chen D, Lin X, Zhang C, An G, Li Z, Dong B, Shen L, Gao J, Zhang X (2019) Activated Wnt signaling promotes growth and progression of AFP-producing gastric cancer in preclinical models. Cancer Manag and Res 11:1349\u20131362. https:\/\/doi.org\/10.2147\/CMAR.S187219","journal-title":"Cancer Manag and Res"},{"key":"5241_CR12","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.3892\/mmr.2018.8455","volume":"17","author":"L Wang","year":"2018","unstructured":"Wang L, Zhao Y, Wu Q, Guan Y, Wu X (2018) Therapeutic effects of beta-elemene via attenuation of the Wnt\/beta-catenin signaling pathway in cervical cancer cells. Mol Med Rep 17:4299\u20134306. https:\/\/doi.org\/10.3892\/mmr.2018.8455","journal-title":"Mol Med Rep"},{"key":"5241_CR13","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1158\/0008-5472.CAN-20-0378","volume":"80","author":"D Shiokawa","year":"2020","unstructured":"Shiokawa D, Sakai H, Ohata H, Miyazaki T, Kanda Y, Sekine S, Narushima D, Hosokawa M, Kato M, Suzuki Y et al (2020) Slow-cycling cancer stem cells regulate progression and chemoresistance in colon cancer. Can Res 80:4451\u20134464. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-0378","journal-title":"Can Res"},{"key":"5241_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/pcan.2017.2","volume":"20","author":"MK Siu","year":"2017","unstructured":"Siu MK, Chen WY, Tsai HY, Chen HY, Yin JJ, Chen CL, Tsai YC, Liu YN (2017) TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer. Prostate Cancer Prostatic Dis 20:172\u2013178. https:\/\/doi.org\/10.1038\/pcan.2017.2","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5241_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3892\/or.2020.7869","volume":"45","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wang Y, Yang H, Huang Z, Wang X, Feng W (2021) TCF7 knockdown inhibits the imatinib resistance of chronic myeloid leukemia K562\/G01 cells by neutralizing the Wnt\/beta-catenin\/TCF7\/ABC transporter signaling axis. Oncol Rep 45:557\u2013568. https:\/\/doi.org\/10.3892\/or.2020.7869","journal-title":"Oncol Rep"},{"key":"5241_CR16","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.2174\/1871520620666201001104928","volume":"21","author":"Z Bai","year":"2021","unstructured":"Bai Z, Wu Y, Yan Y, Bai S, Kang H, Ma W, Zhang J, Gao Y, Hui B, Ma H et al (2021) Downregulation of GPR4 and TCF7 promotes apoptosis and inhibits growth and invasion of ovarian cancer cells. Anticancer Agents Med Chem 21:1544\u20131550. https:\/\/doi.org\/10.2174\/1871520620666201001104928","journal-title":"Anticancer Agents Med Chem"},{"key":"5241_CR17","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.12659\/MSM.913913","volume":"25","author":"X Xu","year":"2019","unstructured":"Xu X, Liu Z, Tian F, Xu J, Chen Y (2019) Clinical significance of transcription factor 7 (TCF7) as a prognostic factor in gastric cancer. Med Sci Monit 25:3957\u20133963. https:\/\/doi.org\/10.12659\/MSM.913913","journal-title":"Med Sci Monit"},{"key":"5241_CR18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle E, Massague J (2019) Transforming growth factor-beta signaling in immunity and cancer. Immunity 50:924\u2013940. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.024","journal-title":"Immunity"},{"key":"5241_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15:178\u2013196. https:\/\/doi.org\/10.1038\/nrm3758","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5241_CR20","doi-asserted-by":"publisher","first-page":"216768","DOI":"10.1016\/j.canlet.2024.216768","volume":"588","author":"J Ding","year":"2024","unstructured":"Ding J, Yang YY, Li PT, Ma Y, Zhang L, Zhou Y, Jin C, Li HY, Zhu YF, Liu XP et al (2024) TGF-beta1\/SMAD3-driven Gli2 isoform expression contributes to aggressive phenotypes of hepatocellular carcinoma. Cancer Lett 588:216768. https:\/\/doi.org\/10.1016\/j.canlet.2024.216768","journal-title":"Cancer Lett"},{"key":"5241_CR21","doi-asserted-by":"publisher","first-page":"E3775","DOI":"10.1073\/pnas.1407074111","volume":"111","author":"M Risolino","year":"2014","unstructured":"Risolino M, Mandia N, Iavarone F, Dardaei L, Longobardi E, Fernandez S, Talotta F, Bianchi F, Pisati F, Spaggiari L et al (2014) Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-beta-SMAD3 pathway in non-small cell lung adenocarcinoma. Proc Natl Acad Sci 111:E3775\u2013E3784. https:\/\/doi.org\/10.1073\/pnas.1407074111","journal-title":"Proc Natl Acad Sci"},{"key":"5241_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s10020-022-00509-1","volume":"28","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Xu Y (2022) FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-beta\/SMAD3 signaling. Mol Med 28:82. https:\/\/doi.org\/10.1186\/s10020-022-00509-1","journal-title":"Mol Med"},{"key":"5241_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41420-021-00657-z","volume":"7","author":"B Hou","year":"2021","unstructured":"Hou B, Li W, Xia P, Zhao F, Liu Z, Zeng Q, Wang S, Chang D (2021) LHP suppresses colorectal cancer cell migration and invasion in vitro and in vivo by inhibiting SMAD3 phosphorylation in the TGF-beta pathway. Cell Death Discovery 7:273. https:\/\/doi.org\/10.1038\/s41420-021-00657-z","journal-title":"Cell Death Discovery"},{"key":"5241_CR24","doi-asserted-by":"publisher","first-page":"14922","DOI":"10.1038\/s41598-023-41504-8","volume":"13","author":"L Xiao","year":"2023","unstructured":"Xiao L, Zhang T, Zheng K, Xiao Q, Zhang W, Zhang D, Wu D, He C, Zhou Y, Liu Y (2023) Knockdown of Secernin 1 inhibits cell invasion and migration by activating the TGF-beta\/SMAD3 pathway in oral squamous cell carcinomas. Sci Rep 13:14922. https:\/\/doi.org\/10.1038\/s41598-023-41504-8","journal-title":"Sci Rep"},{"key":"5241_CR25","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.7150\/jca.37415","volume":"11","author":"D Ye","year":"2020","unstructured":"Ye D, Zhu J, Zhao Q, Ma W, Xiao Y, Xu G, Zhang Z (2020) LMP1 up-regulates calreticulin to induce epithelial-mesenchymal transition via TGF-beta\/SMAD3\/NRP1 pathway in nasopharyngeal carcinoma cells. J Cancer 11:1257\u20131269. https:\/\/doi.org\/10.7150\/jca.37415","journal-title":"J Cancer"},{"key":"5241_CR26","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.3892\/mmr.2020.11624","volume":"22","author":"J Chen","year":"2020","unstructured":"Chen J, Huang X, Li N, Liu B, Ma Z, Ling J, Yang W, Li T (2020) Narasin inhibits tumor metastasis and growth of ERalpha-positive breast cancer cells by inactivation of the TGF-beta\/SMAD3 and IL-6\/STAT3 signaling pathways. Mol Med Rep 22:5113\u20135124. https:\/\/doi.org\/10.3892\/mmr.2020.11624","journal-title":"Mol Med Rep"},{"key":"5241_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2017.02.012","volume":"393","author":"Y Lei","year":"2017","unstructured":"Lei Y, Zhang D, Yu J, Dong H, Zhang J, Yang S (2017) Targeting autophagy in cancer stem cells as an anticancer therapy. Cancer Lett 393:33\u201339. https:\/\/doi.org\/10.1016\/j.canlet.2017.02.012","journal-title":"Cancer Lett"},{"key":"5241_CR28","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.3390\/ijms20112767","volume":"20","author":"Y Hao","year":"2019","unstructured":"Hao Y, Baker D, Ten DP (2019) TGF-beta-mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci 20:2767. https:\/\/doi.org\/10.3390\/ijms20112767","journal-title":"Int J Mol Sci"},{"key":"5241_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2023.10.004","volume":"97","author":"X Wang","year":"2023","unstructured":"Wang X, Eichhorn P, Thiery JP (2023) TGF-beta, EMT, and resistance to anti-cancer treatment. Semin Cancer Biol 97:1\u201311. https:\/\/doi.org\/10.1016\/j.semcancer.2023.10.004","journal-title":"Semin Cancer Biol"},{"key":"5241_CR30","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bbcan.2017.06.006","volume":"1868","author":"S Goossens","year":"2017","unstructured":"Goossens S, Vandamme N, Van Vlierberghe P, Berx G (2017) EMT transcription factors in cancer development re-evaluated: beyond EMT and MET. Biochim Biophys Acta Rev Cancer 1868:584\u2013591. https:\/\/doi.org\/10.1016\/j.bbcan.2017.06.006","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"5241_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12967-015-0617-7","volume":"13","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, Wang W, Wang X (2015) Roles of transcription factor 7 in production of inflammatory factors for lung diseases. J Transl Med 13:273. https:\/\/doi.org\/10.1186\/s12967-015-0617-7","journal-title":"J Transl Med"},{"key":"5241_CR32","doi-asserted-by":"publisher","first-page":"782058","DOI":"10.3389\/fonc.2022.782058","volume":"12","author":"H Rong","year":"2022","unstructured":"Rong H, Cai T, Peng Y, Wang X, Lan T, Ou Z, Qiu L, Li Q, Zhang L, Wu F et al (2022) Correlation between TCF7(+) T cells and prognosis of patients with oral squamous cell carcinoma. Front Oncol 12:782058. https:\/\/doi.org\/10.3389\/fonc.2022.782058","journal-title":"Front Oncol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05241-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05241-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05241-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:53:19Z","timestamp":1778910799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05241-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["5241"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05241-y","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethical Committee of Guangdong Provincial People\u2019s Hospital (KY2024-298\u201302).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study was approved by the Ethical Committee of Guangdong Provincial People\u2019s Hospital (KY2024-298\u201302).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}